Page last updated: 2024-09-03

peroxynitrous acid and Cardiomyopathies

peroxynitrous acid has been researched along with Cardiomyopathies in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's4 (66.67)29.6817
2010's2 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, JJ; Cheng, CF; Chiou, HC; Lian, WS; Lin, H1
Azfer, A; Graham, S; Kolattukudy, PE; Niu, J; Wang, K1
Mabley, JG; Obrosova, IG; Pacher, P; Szabó, C1
Pacher, P; Szabó, C1
García-Estañ, J; Lee, SS; Ortiz, MC1
Bauer, JA; Mihm, MJ; Reiser, PJ; Weinstein, DM; Yu, F1

Reviews

3 review(s) available for peroxynitrous acid and Cardiomyopathies

ArticleYear
Role of nitrosative stress and peroxynitrite in the pathogenesis of diabetic complications. Emerging new therapeutical strategies.
    Current medicinal chemistry, 2005, Volume: 12, Issue:3

    Topics: Animals; Cardiomyopathies; Diabetes Complications; Diabetic Angiopathies; Diabetic Nephropathies; Diabetic Neuropathies; Diabetic Retinopathy; Endothelium, Vascular; Humans; Nitric Oxide; Oxidative Stress; Peroxynitrous Acid; Poly(ADP-ribose) Polymerases; Superoxides; Tyrosine

2005
Role of peroxynitrite in the pathogenesis of cardiovascular complications of diabetes.
    Current opinion in pharmacology, 2006, Volume: 6, Issue:2

    Topics: Animals; Atherosclerosis; Cardiomyopathies; Diabetes Complications; Female; Humans; Male; Oxidative Stress; Peroxynitrous Acid

2006
Nitric oxide and renal and cardiac dysfunction in cirrhosis.
    Clinical science (London, England : 1979), 2002, Volume: 102, Issue:2

    Topics: Animals; Arachidonic Acid; Body Water; Cardiomyopathies; Humans; Kidney Diseases; Liver Cirrhosis; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Peroxynitrous Acid; Rats; Sodium Channels

2002

Other Studies

3 other study(ies) available for peroxynitrous acid and Cardiomyopathies

ArticleYear
The prostaglandin agonist beraprost aggravates doxorubicin-mediated apoptosis by increasing iNOS expression in cardiomyocytes.
    Current vascular pharmacology, 2015, Volume: 13, Issue:1

    Topics: Animals; Apoptosis; Cardiomyopathies; CREB-Binding Protein; Cyclooxygenase 1; Doxorubicin; Epoprostenol; Male; Mice; Mice, Inbred C57BL; Myocardial Ischemia; Myocytes, Cardiac; Nitric Oxide Synthase Type II; Peroxynitrous Acid; Phosphorylation; Prostaglandins; Rats; Rats, Wistar

2015
MCP-1-induced protein attenuates endotoxin-induced myocardial dysfunction by suppressing cardiac NF-кB activation via inhibition of IкB kinase activation.
    Journal of molecular and cellular cardiology, 2011, Volume: 51, Issue:2

    Topics: Animals; Apoptosis; Cardiomyopathies; Cytokines; Disease Models, Animal; Enzyme Activation; Gene Expression Regulation; Heart; I-kappa B Kinase; Inflammation; Lipopolysaccharides; Male; Mice; Mice, Transgenic; Myocardium; NF-kappa B; Nitric Oxide Synthase; Peroxynitrous Acid; Protein Kinase Inhibitors; Ribonucleases; Sepsis

2011
Intracellular distribution of peroxynitrite during doxorubicin cardiomyopathy: evidence for selective impairment of myofibrillar creatine kinase.
    British journal of pharmacology, 2002, Volume: 135, Issue:3

    Topics: Animals; Antineoplastic Agents; Cardiomyopathies; Creatine Kinase; Doxorubicin; Intracellular Fluid; Male; Mice; Myofibrils; Peroxynitrous Acid; Ventricular Dysfunction, Left

2002